{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:20:07Z","timestamp":1772166007774,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI18C1735"],"award-info":[{"award-number":["HI18C1735"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI18C1735"],"award-info":[{"award-number":["HI18C1735"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI18C1735"],"award-info":[{"award-number":["HI18C1735"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI18C1735"],"award-info":[{"award-number":["HI18C1735"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI18C1735"],"award-info":[{"award-number":["HI18C1735"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI18C1735"],"award-info":[{"award-number":["HI18C1735"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To validate a stratification method using an inverse of treatment decision rules that can classify non-small cell lung cancer (NSCLC) patients in real-world treatment records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>(1) To validate the index classifier against the TNM 7th edition, we analyzed electronic health records of NSCLC patients diagnosed from 2011 to 2015 in a tertiary referral hospital in Seoul, Korea. Predictive accuracy, stage-specific sensitivity, specificity, positive predictive value, negative predictive value, F1 score, and c-statistic were measured. (2) To apply the index classifier in an administrative database, we analyzed NSCLC patients in Korean National Health Insurance Database, 2002\u20132013. Differential survival rates among the classes were examined with the log-rank test, and class-specific survival rates were compared with the reference survival rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>(1) In the validation study (N\u2009=\u20091375), the overall accuracy was 93.8% (95% CI: 92.5\u201395.0%). Stage-specific c-statistic was the highest for stage I (0.97, 95% CI: 0.96\u20130.98) and the lowest for stage III (0.82, 95% CI: 0.77\u20130.87). (2) In the application study (N\u2009=\u200971,593), the index classifier showed a tendency for differentiating survival probabilities among classes. Compared to the reference TNM survival rates, the index classification under-estimated the survival probability for stages IA, IIIB, and IV, and over-estimated it for stages IIA and IIB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The inverse of the treatment decision rules has a potential to supplement a routinely collected database with information encoded in the treatment decision rules to classify NSCLC patients. It requires further validation and replication in multiple clinical settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12911-022-02088-x","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T11:09:04Z","timestamp":1673003344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stratifying non-small cell lung cancer patients using an inverse of the treatment decision rules: validation using electronic health records with application to an administrative database"],"prefix":"10.1186","volume":"23","author":[{"given":"Min-Hyung","family":"Kim","sequence":"first","affiliation":[]},{"given":"Sojung","family":"Park","sequence":"additional","affiliation":[]},{"given":"Yu Rang","family":"Park","sequence":"additional","affiliation":[]},{"given":"Wonjun","family":"Ji","sequence":"additional","affiliation":[]},{"given":"Seul-Gi","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Minji","family":"Choo","sequence":"additional","affiliation":[]},{"given":"Seung-Sik","family":"Hwang","sequence":"additional","affiliation":[]},{"given":"Jae Cheol","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Hyeong Ryul","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Chang-Min","family":"Choi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"issue":"6","key":"2088_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2088_CR2","first-page":"303","volume":"50","author":"K-W Jung","year":"2018","unstructured":"Jung K-W, Won Y-J, Kong H-J, Lee ES. Community of population-based regional cancer registries. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat Off J Korean Cancer Assoc. 2018;50(2):303\u201316.","journal-title":"Cancer Res Treat Off J Korean Cancer Assoc"},{"key":"2088_CR3","doi-asserted-by":"crossref","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. John Wiley & Sons; 2016.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"issue":"6","key":"2088_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.6004\/jnccn.2006.0046","volume":"4","author":"DS Ettinger","year":"2006","unstructured":"Ettinger DS, Bepler G, Bueno R, Chang A, Chang JY, Chirieac LR, et al. Non-small cell lung cancer: clinical practice guidelines in oncology\u2122. JNCCN J Natl Compr Cancer Netw. 2006;4(6):548\u201382.","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"issue":"8","key":"2088_CR5","first-page":"706","volume":"2","author":"P Goldstraw","year":"2007","unstructured":"Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2007;2(8):706\u201314.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"1","key":"2088_CR6","first-page":"39","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2016;11(1):39\u201351.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"1","key":"2088_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","volume":"151","author":"FC Detterbeck","year":"2017","unstructured":"Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth edition lung cancer stage classification. Chest. 2017;151(1):193\u2013203.","journal-title":"Chest"},{"issue":"4","key":"2088_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/amiajnl-2014-002747","volume":"21","author":"RL Fleurence","year":"2014","unstructured":"Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc JAMIA. 2014;21(4):578\u201382.","journal-title":"J Am Med Inform Assoc JAMIA"},{"issue":"27","key":"2088_CR9","doi-asserted-by":"publisher","first-page":"7329","DOI":"10.1073\/pnas.1510502113","volume":"113","author":"G Hripcsak","year":"2016","unstructured":"Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113(27):7329\u201336.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"2088_CR10","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","volume":"375","author":"RE Sherman","year":"2016","unstructured":"Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. Real-world evidence\u2014what is it and what can it tell us? N Engl J Med. 2016;375(23):2293.","journal-title":"N Engl J Med"},{"key":"2088_CR11","unstructured":"Kim M-H, Park S, Park YR, Ji W, Kim S, Choo M, et al. Developing computational phenotyping algorithm to classify lung cancer stages using common data elements [Internet]. In: American Medical Informatics Association 2019 Annual Symposium; 2019 Nov 18; Washington, D.C. Available from: https:\/\/www.amia.org\/amia2019"},{"issue":"24","key":"2088_CR12","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1001\/jama.2012.6626","volume":"307","author":"ER Haut","year":"2012","unstructured":"Haut ER, Pronovost PJ, Schneider EB. Limitations of administrative databases. JAMA. 2012;307(24):2589.","journal-title":"JAMA"},{"issue":"60","key":"2088_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2307\/2549561","volume":"15","author":"PA Samuelson","year":"1948","unstructured":"Samuelson PA. Consumption theory in terms of revealed preference. Economica. 1948;15(60):243\u201353.","journal-title":"Economica"},{"issue":"473","key":"2088_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1198\/016214505000000998","volume":"101","author":"RJ Swartz","year":"2006","unstructured":"Swartz RJ, Cox DD, Cantor SB, Davies K, Follen M. Inverse decision theory: characterizing losses for a decision rule with applications in cervical cancer screening. J Am Stat Assoc. 2006;101(473):1\u20138.","journal-title":"J Am Stat Assoc"},{"key":"2088_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jbi.2014.02.013","volume":"48","author":"K Hajian-Tilaki","year":"2014","unstructured":"Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform. 2014;48:193\u2013204.","journal-title":"J Biomed Inform"},{"key":"2088_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.lungcan.2017.12.013","volume":"116","author":"EJM Driessen","year":"2018","unstructured":"Driessen EJM, Schulkes KJG, Dingemans A-MC, Van Loon JGM, Hamaker ME, Aarts MJ, et al. Patterns of treatment and survival among older patients with stage III non-small cell lung cancer. Lung Cancer Amst Neth. 2018;116:55\u201361.","journal-title":"Lung Cancer Amst Neth"},{"issue":"2","key":"2088_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/A:1010920819831","volume":"45","author":"DJ Hand","year":"2001","unstructured":"Hand DJ, Till RJ. A simple generalisation of the area under the ROC curve for multiple class classification problems. Mach Learn. 2001;45(2):171\u201386.","journal-title":"Mach Learn"},{"key":"2088_CR18","doi-asserted-by":"crossref","unstructured":"Davis J, Goadrich M. The relationship between precision-recall and ROC curves. In: Proceedings of the 23rd international conference on Machine learning. ACM; 2006. pp. 233\u201340.","DOI":"10.1145\/1143844.1143874"},{"issue":"10","key":"2088_CR19","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jama.2015.11082","volume":"314","author":"MJ Pencina","year":"2015","unstructured":"Pencina MJ, D\u2019Agostino RB. Evaluating discrimination of risk prediction models: the C statistic. JAMA. 2015;314(10):1063\u20134.","journal-title":"JAMA"},{"key":"2088_CR20","doi-asserted-by":"publisher","first-page":"e2014008","DOI":"10.4178\/epih\/e2014008","volume":"30","author":"L Kim","year":"2014","unstructured":"Kim L, Kim J-A, Kim S. A guide for the utilization of health insurance review and assessment service national patient samples. Epidemiol Health. 2014;30:e2014008.","journal-title":"Epidemiol Health"},{"issue":"2","key":"2088_CR21","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1093\/ije\/dyv319","volume":"46","author":"J Lee","year":"2017","unstructured":"Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort profile: the national health insurance service-national sample cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017;46(2):e15. https:\/\/doi.org\/10.1093\/ije\/dyv319","journal-title":"Int J Epidemiol."},{"issue":"4","key":"2088_CR22","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.4143\/crt.2018.704","volume":"51","author":"CM Choi","year":"2019","unstructured":"Choi CM, Kim HC, Jung CY, Cho DG, Jeon JH, Lee JE, Ahn JS, Kim SJ, Kim Y, Choi YD, Suh YG, Kim JE, Lee B, Won YJ, Kim YC. Report of the Korean Association of Lung Cancer Registry (KALC-R), 2014. Cancer Res Treat. 2019;51(4):1400\u201310. https:\/\/doi.org\/10.4143\/crt.2018.704.","journal-title":"Cancer Res Treat."},{"issue":"14","key":"2088_CR23","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/jama.2020.1267","volume":"323","author":"MJ Stensrud","year":"2020","unstructured":"Stensrud MJ, Hern\u00e1n MA. Why test for proportional hazards? JAMA. 2020;323(14):1401\u20132. https:\/\/doi.org\/10.1001\/jama.2020.1267.","journal-title":"JAMA."},{"issue":"351","key":"2088_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5527","volume":"28","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;28(351): h5527.","journal-title":"BMJ"},{"issue":"11","key":"2088_CR25","doi-asserted-by":"publisher","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","volume":"6","author":"JF Cohen","year":"2016","unstructured":"Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6(11):e012799.","journal-title":"BMJ Open"},{"key":"2088_CR26","first-page":"2","volume":"1","author":"GH Knibbs","year":"1929","unstructured":"Knibbs GH. The international classification of disease and causes of death and its revision. Med J. 1929;1:2\u201312.","journal-title":"Med J"},{"issue":"15","key":"2088_CR27","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1056\/NEJMra1615014","volume":"379","author":"MA Haendel","year":"2018","unstructured":"Haendel MA, Chute CG, Robinson PN. Classification, ontology, and precision medicine. N Engl J Med. 2018;379(15):1452\u201362.","journal-title":"N Engl J Med"},{"issue":"9","key":"2088_CR28","first-page":"1433","volume":"11","author":"FC Detterbeck","year":"2016","unstructured":"Detterbeck FC, Chansky K, Groome P, Bolejack V, Crowley J, Shemanski L, et al. The IASLC Lung cancer staging project: methodology and validation used in the development of proposals for revision of the stage classification of NSCLC in the forthcoming (Eighth) edition of the TNM classification of lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2016;11(9):1433\u201346.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"1","key":"2088_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/09332480.2019.1579578","volume":"32","author":"MA Hern\u00e1n","year":"2019","unstructured":"Hern\u00e1n MA, Hsu J, Healy B. A second chance to get causal inference right: a classification of data science tasks. Chance. 2019;32(1):42\u20139.","journal-title":"Chance"},{"issue":"1","key":"2088_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12916-019-1426-2","volume":"17","author":"CJ Kelly","year":"2019","unstructured":"Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 2019;17(1):195.","journal-title":"BMC Med"},{"issue":"8","key":"2088_CR31","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nbt0806-942","volume":"24","author":"V Ozdemir","year":"2006","unstructured":"Ozdemir V, Williams-Jones B, Glatt SJ, Tsuang MT, Lohr JB, Reist C. Shifting emphasis from pharmacogenomics to theragnostics. Nat Biotechnol. 2006;24(8):942\u20136.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2088_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/thno.21052","volume":"8","author":"XS Chen","year":"2011","unstructured":"Chen XS. Introducing theranostics journal\u2014from the editor-in-chief. Theranostics. 2011;8(1):1\u20132.","journal-title":"Theranostics"},{"issue":"16","key":"2088_CR33","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1001\/jama.2012.13664","volume":"308","author":"M Smith","year":"2012","unstructured":"Smith M, Halvorson G, Kaplan G. What\u2019s needed is a health care system that learns: recommendations from an IOM report. JAMA. 2012;308(16):1637\u20138.","journal-title":"JAMA"},{"issue":"34","key":"2088_CR34","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1200\/JCO.2012.42.8011","volume":"30","author":"BJ Miriovsky","year":"2012","unstructured":"Miriovsky BJ, Shulman LN, Abernethy AP. Importance of health information technology, electronic health records, and continuously aggregating data to comparative effectiveness research and learning health care. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(34):4243\u20138.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"7","key":"2088_CR35","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1001\/jamainternmed.2017.2589","volume":"177","author":"AB Bindman","year":"2017","unstructured":"Bindman AB. The agency for healthcare research and quality and the development of a learning health care system. JAMA Intern Med. 2017;177(7):909\u201310.","journal-title":"JAMA Intern Med"},{"issue":"13","key":"2088_CR36","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2012.404","volume":"307","author":"MSV Sarrazin","year":"2012","unstructured":"Sarrazin MSV, Rosenthal GE. Finding pure and simple truths with administrative data. JAMA. 2012;307(13):1433\u20135.","journal-title":"JAMA"},{"issue":"1","key":"2088_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/amiajnl-2012-001145","volume":"20","author":"G Hripcsak","year":"2013","unstructured":"Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. J Am Med Inform Assoc JAMIA. 2013;20(1):117\u201321.","journal-title":"J Am Med Inform Assoc JAMIA"},{"issue":"8","key":"2088_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/01.mlr.0000132391.59713.0d","volume":"42","author":"H Quan","year":"2004","unstructured":"Quan H, Parsons GA, Ghali WA. Validity of procedure codes in international classification of diseases, 9th revision, clinical modification administrative data. Med Care. 2004;42(8):801\u20139.","journal-title":"Med Care"},{"issue":"4","key":"2088_CR39","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2307\/1912971","volume":"40","author":"MR Wickens","year":"1972","unstructured":"Wickens MR. A note on the use of proxy variables. Econometrica. 1972;40(4):759\u201361.","journal-title":"Econometrica"},{"issue":"8","key":"2088_CR40","first-page":"694","volume":"2","author":"PA Groome","year":"2007","unstructured":"Groome PA, Bolejack V, Crowley JJ, Kennedy C, Krasnik M, Sobin LH, et al. The IASLC lung cancer staging project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2007;2(8):694\u2013705.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"1","key":"2088_CR41","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtcvs.2018.08.075","volume":"157","author":"C Cao","year":"2019","unstructured":"Cao C, Wang D, Chung C, Tian D, Rimner A, Huang J, et al. A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019;157(1):362\u201373.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"12","key":"2088_CR42","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/jjco\/hyx147","volume":"47","author":"S-I Watanabe","year":"2017","unstructured":"Watanabe S-I, Nakagawa K, Suzuki K, Takamochi K, Ito H, Okami J, et al. Neoadjuvant and adjuvant therapy for stage III non-small cell lung cancer. Jpn J Clin Oncol. 2017;47(12):1112\u20138.","journal-title":"Jpn J Clin Oncol"},{"issue":"36","key":"2088_CR43","doi-asserted-by":"publisher","first-page":"24470","DOI":"10.18632\/oncotarget.25327","volume":"9","author":"M MacLean","year":"2018","unstructured":"MacLean M, Luo X, Wang S, Kernstine K, Gerber DE, Xie Y. Outcomes of neoadjuvant and adjuvant chemotherapy in stage 2 and 3 non-small cell lung cancer: an analysis of the national cancer database. Oncotarget. 2018;9(36):24470\u20139.","journal-title":"Oncotarget"},{"issue":"4","key":"2088_CR44","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.21037\/jtd.2019.03.42","volume":"11","author":"X Tao","year":"2019","unstructured":"Tao X, Yuan C, Zheng D, Ye T, Pan Y, Zhang Y, et al. Outcomes comparison between neoadjuvant chemotherapy and adjuvant chemotherapy in stage IIIA non-small cell lung cancer patients. J Thorac Dis. 2019;11(4):1443\u201355.","journal-title":"J Thorac Dis"},{"issue":"4","key":"2088_CR45","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1378\/chest.129.4.1088","volume":"129","author":"H Sugimura","year":"2006","unstructured":"Sugimura H, Yang P. Long-term survivorship in lung cancer: a review. Chest. 2006;129(4):1088\u201397.","journal-title":"Chest"},{"issue":"12","key":"2088_CR46","first-page":"2844","volume":"75","author":"M Noguchi","year":"1995","unstructured":"Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, et al. Small adenocarcinoma of the lung. Histol Charact Progn Cancer. 1995;75(12):2844\u201352.","journal-title":"Histol Charact Progn Cancer"},{"issue":"11","key":"2088_CR47","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1001\/jamaoncol.2017.1609","volume":"3","author":"B Li","year":"2017","unstructured":"Li B, Cui Y, Diehn M, Li R. Development and validation of an individualized immune prognostic signature in early-stage nonsquamous non-small cell lung cancer. JAMA Oncol. 2017;3(11):1529\u201337.","journal-title":"JAMA Oncol"},{"issue":"18","key":"2088_CR48","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1158\/1078-0432.CCR-09-0376","volume":"15","author":"JM Samet","year":"2009","unstructured":"Samet JM, Avila-Tang E, Boffetta P, Hannan LM, Olivo-Marston S, Thun MJ, et al. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res Off J Am Assoc Cancer Res. 2009;15(18):5626\u201345.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"6312","key":"2088_CR49","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1126\/science.aag0299","volume":"354","author":"LB Alexandrov","year":"2016","unstructured":"Alexandrov LB, Ju YS, Haase K, Van Loo P, Martincorena I, Nik-Zainal S, et al. Mutational signatures associated with tobacco smoking in human cancer. Science. 2016;354(6312):618\u201322.","journal-title":"Science"},{"issue":"5","key":"2088_CR50","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1200\/JCO.2006.07.2983","volume":"25","author":"HA Wakelee","year":"2007","unstructured":"Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, et al. Lung cancer incidence in never smokers. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(5):472\u20138.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"2088_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40880-017-0187-6","volume":"36","author":"J Cho","year":"2017","unstructured":"Cho J, Choi SM, Lee J, Lee C-H, Lee S-M, Kim D-W, et al. Proportion and clinical features of never-smokers with non-small cell lung cancer. Chin J Cancer. 2017;36(1):20.","journal-title":"Chin J Cancer"},{"issue":"34","key":"2088_CR52","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1200\/JCO.2008.16.7254","volume":"26","author":"T Takano","year":"2008","unstructured":"Takano T, Fukui T, Ohe Y, Tsuta K, Yamamoto S, Nokihara H, et al. EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(34):5589\u201395.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"2088_CR53","first-page":"438","volume":"10","author":"Y Yatabe","year":"2015","unstructured":"Yatabe Y, Kerr KM, Utomo A, Rajadurai P, Tran VK, Du X, et al. EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2015;10(3):438\u201345.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"9111","key":"2088_CR54","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/S0140-6736(97)08229-9","volume":"351","author":"S Sone","year":"1998","unstructured":"Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet Lond Engl. 1998;351(9111):1242\u20135.","journal-title":"Lancet Lond Engl"},{"key":"2088_CR55","doi-asserted-by":"crossref","unstructured":"National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395\u2013409.","DOI":"10.1056\/NEJMoa1102873"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-02088-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-022-02088-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-02088-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T14:02:31Z","timestamp":1673100151000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-022-02088-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2088"],"URL":"https:\/\/doi.org\/10.1186\/s12911-022-02088-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-149948\/v1","asserted-by":"object"}]},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol using EHR data was approved by the AMC (IRB no. AMC 2018\u20131515). The data were deidentified and consent requirements were waived by the Internal Review Board (IRB). The study protocol was approved by the NHI, Korea (IRB no. 2015\u20130236). The data were deidentified and the consent requirements were waived by the IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest related to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}